Actively Recruiting
A Prospective Study on Clinical Outcomes and Quality of Life in Chinese Patients with Chronic Rhinosinusitis with Nasal Polyps After Surgery
Led by AstraZeneca · Updated on 2026-07-08
200
Participants Needed
18
Research Sites
N/A
Total Duration
AI-Summary
What this Trial Is About
Researchers are conducting a prospective, multicenter real-world study to observe the postoperative outcomes, quality of life, disease control, patient characteristics, economic burden, and treatment patterns in Chinese patients with Chronic Rhinosinusitis with Nasal Polyps CRSwNP who have undergone surgery. The study focuses on patients who have experienced recurrence and aims to provide a detailed understanding of their clinical trajectory and well-being after surgery. Participants will undergo a standard surgical procedure called Functional Endoscopic Sinus Surgery FESS as part of routine clinical care. This procedure is not experimental and will be performed according to local guidelines and the treating physicians discretion. The study will follow participants for 52 weeks after surgery, monitoring various clinical outcomes through scheduled assessments. Throughout the study, participants will receive standard medical care as determined by their physicians and attend scheduled clinical evaluations. Researchers will collect data on symptom scores, nasal polyp assessments, CT imaging, quality of life measures, medication use, and recurrence rates. The study aims to track changes in these measures from baseline up to 52 weeks post-surgery to better understand patient recovery and disease management over time.
CONDITIONS
Brief Title
A Study to Investigate the Clinical Outcome and Quality of Life in Chinese Post-operative CRSwNP Patients
Research Team
A
AstraZeneca Clinical Study Information Center
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here